Symptomatic intraocular pressure dysregulation during clopidogrel exposure after patent foramen ovale closure in a patient with ocular hypertension and angle crowding: a Case Report - Top-Institutions - MDSpire

Intraocular Pressure Dysregulation Symptoms Associated with Clopidogrel Treatment Following Patent Foramen Ovale Closure in a Patient with Ocular Hypertension and Angle Crowding: A Case Study

  • By

  • Faxue Li

  • Rongbo Yu

  • Xuan Guo

  • Wenyi Ji

  • Qiang Wu

  • July 16, 2026

Share

Top Institutions in Ophthalmology

Brief introduction explaining scope and methodology.

  • #1

    Bascom Palmer Eye Institute, University of Miami
    Bascom Palmer Eye Institute, University of Miami

    Miami, Florida

    Key Differentiators

    • Glaucoma
    • Ocular Hypertension

  • #2

    Wills Eye Hospital
    Wills Eye Hospital

    Philadelphia, Pennsylvania

    Key Differentiators

    • Glaucoma
    • Angle-Closure Evaluation

  • #3

    Zhongshan Ophthalmic Center
    Zhongshan Ophthalmic Center

    Guangzhou, China

    Key Differentiators

    • Angle-Closure Prevention
    • Glaucoma

Original Source(s)

Symptomatic intraocular pressure dysregulation during clopidogrel exposure after patent foramen ovale closure in a patient with ocular hypertension and angle crowding: a Case Report

  • by Faxue Li, Rongbo Yu, Xuan Guo, Wenyi Ji, Qiang Wu

  • July 16, 2026

Related Content

Stuart Therapeutics Spotlights Topical RP Program

At OIS Retina, Eric Schlumpf discussed the company’s collagen mimetic peptide platform for retinitis pigmentosa, now in preclinical development.

ASRS President Reflects on a Year of Change

As his term comes to a close, Geoffrey G. Emerson, MD, PhD, FASRS, discusses scientific advances, physician advocacy, and the collaborative leadership behind ASRS.

Can Patients Switch to Biosimilar Aflibercept?

A 20-week INSIGHT extension suggests that switching from reference aflibercept to MYL-1701P maintained comparable safety, visual, and anatomic outcomes in patients with diabetic macular edema.